Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6116543 | Diagnostic Microbiology and Infectious Disease | 2011 | 4 Pages |
Abstract
Beta-lactam-resistant Enterobacteriaceae represent an important public health problem; however, questions exist about their prevalence and the impact of recent breakpoint changes on clinical practice. We surveyed infectious disease physicians to better understand these issues. Many reported encountering resistant Enterobacteriaceae; respondents generally favored a more conservative interpretation of antimicrobial susceptibility results.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Alexander J. Kallen, Susan E. Beekmann, Brandi Limbago, Arnold L. Lentnek, Philip M. Polgreen, Jean Patel, Arjun Srinivasan,